Overview

Symptom Management After Breast Cancer Surgery

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
0
Participant gender:
Female
Summary
This trial is part of a larger, longitudinal study of symptoms that occur in the breast surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop pain in the breast scar area or ipsilateral arm will be randomized to a placebo patch or a lidocaine patch that they will wear on a daily basis for 12 weeks. We hypothesize that women who wear the lidocaine patch will report a decrease in pain and decreased interference with function compared to women who wear the placebo patch.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

- Adult women >18 years who develop neuropathic pain in the breast scar area and/or
ipsilateral arm following breast cancer surgery

- Has a healed incision(s)

- Has no recurrent disease in the painful area

- Is able to read, write and understand English

Exclusion Criteria:

- Presence of another type of pain that is more severe than the neuropathic pain

- Use of an opioid analgesic of greater than 60 mg codeine/day

- Is actively trying to become pregnant

- Has a medical contraindication to the use of lidocaine

- Has an allergy to lidocaine

- Is taking a coanalgesic for neuropathic pain.